Stay updated with breaking news from Specific Membrane Antigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
05.09.2022 - Poster #1400P will be presented on Sunday, September 11 by Dr. Aaron R. HansenINDIANAPOLIS, Sept. 04, 2022 (GLOBE NEWSWIRE) - POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating the discovery, development, ... Seite 1
18.08.2022 - In advance of the abstract publication, POINT hosted an educational webinar entitled “Understanding the PNT2002 Phase 3 SPLASH Trial Control Arm” Watch the replay at https://hub.pointbiopharma.com/controlarm INDIANAPOLIS, Aug. 18, 2022 (GLOBE ... Seite 1
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
The wide-ranging market information of the CAR-T Therapy Treatment Market report will surely grow business and improve return on investment (ROI). This market research report gives CAGR values along with their fluctuations for the specific forecast period. The market report has been prepared by taking into account s...
Telix Pharmaceuticals Limited: Telix Commences Phase III Clinical Trial of Prostate Cancer Therapy MELBOURNE, Australia, May 09, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has been granted Human Research Ethics Committee (HREC) approval and received Clinical Trial Notification (CTN) clearance by the Australian Therapeutic Goods Administration (TGA) to commence a Phase III clinical trial of the Company's PSMA 1 targeted prostate cancer therapy candidate TLX591 ( 177Lu-DOTA-rosopatamab), in patients with advanced metastatic castrate-...